Immunolocalisation of heat shock protein 72 and glycoprotein 96 in colonic adenocarcinoma

Acta Histochemica

Volumn 110, Issue 2, 2008, Pages 117-123

  Wang, Xiaoping ^a   Wang, Qiaoxia ^a   Guo, Lansheng ^a   Ying, Xiaoping ^a   Zhao, Yanhong ^a  

^a SHAANXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Adenocarcinoma; Colon; Glycoprotein 96; Heat shock protein 72; Human; Prognosis

Indexed keywords

GLYCOPROTEIN GP 96; HEAT SHOCK PROTEIN 72;

ANTIBODY LABELING; ARTICLE; CANCER GROWTH; CARCINOGENESIS; COLON ADENOCARCINOMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; METASTASIS; MUCOSA; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADENOCARCINOMA; ADULT; AGED; ANTIBODIES, NEOPLASM; COLONIC NEOPLASMS; FEMALE; HSP72 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED;

EID: 39949085239     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2007.10.013     Document Type: Article

References (33)

1. Argon Y., and Simen B.B. GRP96, an ER chaperone with protein and peptide binding properties. Semin Cell Dev Biol 10 (1999) 495-505
2. Bausero M.A., Page D.T., Osinaga E., and Asea A. Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis. Tumour Biol 25 (2004) 243-251
3. Cardoso F., Di-Leo A., Larsimont D., Gancberg D., Rouas G., Dolci S., et al. Evaluation of HER2, p53, bcl-2, topoisomerase II-alpha, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes. Ann Oncol 12 (2001) 615-620
4. Castelli C., Rivoltini L., Rini F., Belli F., Testori A., Maio M., et al. Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer. Cancer Immunol Immunother 53 (2004) 227-233
5. Dorsey W.C., and Tchounwou P.B. CYP1a1, HSP70, P53, and c-fos expression in human liver carcinoma cells (HepG2) exposed to pentachlorophenol. Biomed Sci Instrum 39 (2003) 386-389
6. Faure O., Graff-Dubois S., Bretaudeau L., Derre L., Gross D.A., Alves P.M., et al. Inducible Hsp70 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes. Int J Cancer 108 (2004) 863-870
7. Fisher D.L., Mandart E., and Doree M. Hsp90 is required for c-Mos activation and biphasic MAP kinase activation in Xenopus oocytes. EMBO J 19 (2000) 1516-1524
8. Fu Y., and Lee A.S. Glucose regulated proteins in cancer progression, drug resistance and immunotherapy. Cancer Biol Ther 5 (2006) 741-744
9. Gabai V.L., Budagova K.R., and Sherman M.Y. Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents. Oncogene 24 (2005) 3328-3338
10. Garcia-Bermejo L., Vilaboa N.E., Perez C., Galan A., De-BlaS E., and Aller P. Modulation of heat-shock protein 70 (HSP70) gene expression by sodium butyrate in U-937 promonocytic cells: relationships with differentiation and apoptosis. Exp Cell Res 236 (1997) 268-274
11. Graner M.W., Zeng Y., Feng H., and Katsanis E. Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunol Immunother 52 (2003) 226-234
12. Hwang T.S., Han H.S., Choi H.K., Lee Y.J., Kim Y.J., Han M.Y., et al. Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer. J Gastroenterol Hepatol 18 (2003) 690-700
13. Isomoto H., Oka M., Yano Y., Kanazawa Y., Soda H., Terada R., et al. Expression of heat shock protein (Hsp) 70 and Hsp 40 in colonic cancer. Cancer Lett 198 (2003) 219-228
14. Kato K., Yamanaka K., Nakano M., Hasegawa A., and Okada S. 72-kDa stress protein (hsp72) induced by administration of dimethylarsinic acid to mice accumulates in alveolar flat cells of lung, a target organ for arsenic carcinogenesis. Biol Pharm Bull 23 (2000) 1212-1215
15. King F.W., Wawrzynow A., Hohfeld J., and Zylicz M. Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53. EMBO J 20 (2001) 6297-6305
16. Lebret T., Watson R.W., Molinie V., O'neill A., Gabriel C., Fitzpatrick J.M., et al. Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma. Cancer 98 (2003) 970-977
17. Lee A.S. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci 26 (2001) 504-510
18. Linderoth N.A., Simon M.N., Rodionova N.A., Cadene M., Laws W.R., Chait B.T., et al. Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP96 and its complex with peptide antigen. Biochemistry 40 (2001) 1483-1495
19. Liu H., Vuyyuru V.B., Pham CD Yang Y., and Singh B. Evidence of an interaction between Mos and Hsp70: a role of the Mos residue serine 3 in mediating Hsp70 association. Oncogene 18 (1999) 3461-3470
20. Lopez-Cotarelo C., Sellhaus B., Baba H.A., Manegold E., Luka J., Handt S., et al. Expression of heat shock proteins 72/73 in human peritoneal mesothelial cells in vivo and in vitro. Nephron 85 (2000) 148-155
21. Maehara Y., Oki E., Abe T., Tokunaga E., Shibahara K., Kakeji Y., et al. Overexpression of the heat shock protein HSP70 family and p53 protein and prognosis for patients with gastric cancer. Oncology 58 (2000) 144-151
22. Milicevic Z.T., Petkovic M.Z., Drndarevic N.C., Pavlovic M.D., and Todorovic V.N. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma immunohistochemistry and Western blot analysis. Neoplasma 54 (2007) 37-45
23. Morimoto R.I. Cells in stress: transcriptional activation of heat shock genes. Science 259 (1993) 1409-1410
24. Multhoff G., Botzler C., Jennen L., Schmidt J., Ellwart J., and Issels R. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J Immunol 158 (1997) 4341-4350
25. Renan M.J. Cancer genes: current status, future prospects, and applications in radiotherapy/oncology. Radiother Oncol 19 (1990) 197-218
26. Schlesinger M.J. Heat shock proteins. J Biol Chem 265 (1990) 12111-12114
27. Villaseca M.A., Roa I., Araya J.C., Roa J.C., and Flores P. Double immunostaining for p53 and molecular chaperone hsp72/73 in gastric carcinoma. Mol Pathol 50 (1997) 317-321
28. Volloch V.Z., and Sherman M.Y. Oncogenic potential of Hsp72. Oncogene 18 (1999) 3648-3651
29. Wang Q., An L., Chen Y., and Yue S. Expression of endoplasmic reticulum molecular chaperon GRP96 in human lung cancer tissues and its clinical significance. Chin Med J 115 (2002) 1615-1619
30. Wang Q., He Z., Zhang J., Wang Y., Wang T., Tong S., et al. Overexpression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance. Cancer Detect Prev 29 (2005) 544-551
31. Wang X.P., Qiu F.R., Liu G.Z., and Chen R.F. Correlation between clinicopathology and expression of heat shock protein 70 and glucose-regulated protein 94 in human colonic adenocarcinoma. World J Gastroenterol 11 (2005) 1056-1059
32. Wang X.P., Wang Q.X., and Ying X.P. Correlation between clinicopathology and expression of heat shock protein 72 and glycoprotein 96 in human gastric adenocarcinoma. Tohoku J Exp Med 212 (2007) 35-41
33. Zhang H., Hu H., Jiang X., He H., Cui L., and He W. Membrane HSP70: the molecule triggering gammadelta T cells in the early stage of tumorigenesis. Immunol Invest 34 (2005) 453-468